Tracing Ex-RFK Jr. adviser says Trump admin corruption prompted resignation×Refreshed 1 min ago
All24 hours
Vertical
- All verticals
- Space
- Energy
- Quantum
- Robotics
- Cybersecurity
- Biotechnology
- Defense Tech
- Artificial Intelligence
× Show allIn focus
ARPA-E funds transuranic reactor fuel projects as Curio and Newcleo plan recycled fuel
ARPA-E selected eight HORNIG teams, with up to $50 million combined, to develop transuranic-based advanced reactor fuels, and INL will lead one project to irradiate a molten salt fuel in the Advanced Test Reactor. Separately, Curio agreed to supply recovered plutonium and uranium to Newcleo's proposed MOX plant at Savannah River Site, which has not yet applied for an NRC license. The items show no scheduled hearing, vote or deadline. · 2d ago
Forces, money & more EnergyIn the News
One card per story, every outlet that covered it30YesterdayYahooSenator proposes select committee on AI as Democrats hope to move quickly to regulate itColorado Sen. John Hickenlooper proposed a Senate select committee on AI and pressed the Senate leadership candidates to commit to a day-one AI regulation plan ahead of the next Congress.1 outletAILawmakers push AI safety bills after GAO chatbot attack-planning test20 linked 2d agoYahooCancer Vaccines Are Advancing. Can Regulators Keep Up?Reason Magazine argues that rapid advances in personalized cancer vaccines show the FDA's drug approval monopoly is ill-suited to fast-moving medicine and should be replaced by competing certification organizations. Biotech36 linked2 articles
- 2d agoYahooEarliestCancer Vaccines Are Advancing. Can Regulators Keep Up?
- 2d agoReasonPickupCancer Vaccines Are Advancing. Can Regulators Keep Up?
4d agoYahooWhite House pulls FDA nominee Heidi Overton after wavering support from Senate RepublicansSTAT's Readout Loud podcast episode covers the Trump administration withdrawing Heidi Overton's FDA commissioner nomination, the FDA's rejection of Summit Therapeutics and Akeso's lung cancer drug, and STAT's new index ranking China's largest drugmakers. Biotech66 linked4 articles · 2 outlets
- 4d agoSTATSTAT+: White House pulls nomination of Heidi Overton to lead FDA
- 4d agoYahooPickupWhite House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans
- 3d agoSTATSTAT+: 7 burning questions about the FDA’s post-Overton future
- 2d agoSTATEarliestFDA’s search for a new leader, and China’s largest drugmakers
2d agoYahooSanders Sounds Warning Bell On Multifaceted Threats Posed By AI. He Could Influence The Democrats' AI Policy.Sanders used a Diary Of A CEO podcast interview to warn about AI's job, privacy and social risks and reaffirmed his support for the Ban Artificial Superintelligence Act and a pause on advanced AI.1 outletAILawmakers push AI safety bills after GAO chatbot attack-planning test18 linked 3d agoReasonBernie Sanders' 'Superintelligence' Ban Would Criminalize Today's AI for What Tomorrow's AI Might DoReason opinion argues the Sanders–Casar Ban Artificial Superintelligence Act would criminalize current AI for potential future capabilities, citing vague precursor traits and harsh penalties.1 outletAI9 linked 2d agoYahooFDA sets up council for post-market review of vaccines, gene therapiesFDA established the CBER Safety Council within its biologics center to formalize independent post-market safety review of approved vaccines, gene therapies and blood products, replacing the existing Safety Working Group.1 outletBiotech23 linked 3d agoFortuneThe midterms weren’t really about data centers. An AI researcher says voters want a pause on AI itselfFortune argues that Democrats, having won on anger over AI data centers and power bills, need to weigh moratoriums, congressional oversight, state utility cost rules, and tech-industry deals against the economic value of AI investment. AIVoters back data center limits as states and counties move to pause projects56 linked2 articles
3d agoAxios · research by Rhodium GroupWhy the Senate energy permitting bill might become lawThe Senate advanced Sen. Martin Heinrich's Bipartisan American Affordability and Jobs Act, a permitting reform bill to speed federal environmental reviews of energy projects, by a 73-25 cloture vote on Nov. 9, 2026, over opposition from tribes and environmental groups. EnergySenate passes bipartisan permitting bill 62-33, sends it to House936 linked16 articles · 8 outlets · The Guardian
- Nov 5Source NMNew analyses contend New Mexico US Sen. Heinrich’s permitting bill would cut emissions, costs
- 12d agoThe GuardianSenate votes on bill to speed up projects from gas pipelines to clean energy
- 12d agoYahooPickupDemocratic US senators see hope for permitting bill ahead of key Senate vote
- 12d agoLatitude MediaPickupSenate’s bipartisan permitting bill faces crucial test
- 12d agoSource NMEarliestUS Senate advances New Mexico US Sen. Heinrich’s controversial permit reform bill
- 11d agoInside Climate NewsSenate Advances Permitting Overhaul But Roadblocks Loom
- 11d agoReasonPickupSenate Advances Bipartisan Permitting Bill That Could Unleash Energy Development With Major Caveats
- 11d agoYahooPickupSenate Advances Bipartisan Permitting Bill That Could Unleash Energy Development With Major Caveats
- 10d agoYahooPickupMany liberals hate this bill to overhaul permitting. Democrats may help pass it anyway.
- 10d agoYahooPickupMany liberals hate this bill to overhaul permitting. Democrats may help pass it anyway.
- 6d agoThe GuardianPassing bill to speed up gas projects and datacenters would be ‘serious mistake’, Al Gore says
- 5d agoThird Way EnergyPickupBuilding More While Paying Less: The State-by-State Savings from Permitting Reform
- 5d agoInside Climate NewsThe New Rules of Permitting
- 4d agoYahooPickupNew Mexico US Sen. Heinrich’s permitting bill takes another step toward US Senate passage
- 3d agoAxiosWhy the Senate energy permitting bill might become law
- 2d agoInside Climate NewsHow the Bipartisan Permitting Bill Could Drive Up Natural Gas Exports
6d agoYahooBill Cassidy says Trump’s FDA pick faces uncertain committee voteSenate HELP Chair Bill Cassidy says he still has questions about FDA commissioner nominee Heidi Overton, leaving the outcome of Wednesday's committee vote uncertain.1 outlet19 linked 12d agoAl JazeeraUS agencies unite to combat rogue drone threats nationwideFive federal departments signed a new interagency MOU to unify how counter-drone technologies are tested and deployed in U.S. civilian airspace, led by the White House Task Force to Restore American Airspace Sovereignty. RoboticsDefenseFederal agencies sign memo to speed counter-drone deployment in US airspace153 linked4 articles · 2 outlets
- 12d agoAl JazeeraPickupUS agencies unite to combat rogue drone threats nationwide
- 12d agoDefenseScoopEarliestAgencies agree to counter unauthorized drones without compromising civilian safety, under new MOU
- 11d agoDefenseScoopHegseth issues ‘corrected copy’ of recently unveiled counter-drone guidance
- 9d agoDefenseScoopCounter-UAS task force turns to Intelligence Community for input on real-world threat assessments
11d agoSTATSTAT+: Cassidy sets key vote on Overton, even as he remains undecided on nominee to lead FDASenate HELP Committee schedules a Nov. 18 vote on FDA commissioner nominee Heidi Overton, with Chair Bill Cassidy still undecided.1 outletBiotech6 linked 11d agoLos Angeles TimesInside the world of San Francisco 'peptide parties' — including one aboard a World War II shipHHS's enforcement discretion policy lets pharmacies compound six unapproved peptides ahead of a final FDA rule, which critics say expands access without adequate safety or efficacy evidence.1 outletBiotech12 linked 11d agoVanity FairLobbyists Are Preparing Silicon Valley Titans for Democratic Subpoenas and Congressional CrackdownVanity Fair reports that tech lobbyists are preparing Silicon Valley firms for expected Democratic congressional subpoenas and possible narrow AI, crypto, and antitrust crackdowns after the 2026 midterms.1 outletAI8 linked 13d agoYahooStephen Miller Is the Real President NowTrump replaces White House chief of staff Susie Wiles with Stephen Miller after the midterm losses, effective November 9, 2026. 54 linked5 articles · 4 outlets · Axios
- Nov 6SemaforTrump elevates Stephen Miller after midterms disaster
- Nov 6Roll CallPickupTrump names Stephen Miller his chief of staff ahead of Dem takeover
- Nov 6AxiosEarliestTrump replaces chief of staff Susie Wiles with Stephen Miller
- Nov 7AxiosTrump's "war-time consigliere" and the Miller Doctrine
- 13d agoYahooPickupStephen Miller Is the Real President Now
13d agoSTATSTAT+: FDA warns GLP-1 drugs carry potential risk of rare eye conditionFDA ordered GLP-1 drug makers to add safety labeling warning patients and doctors of a potential risk of the rare eye condition NAION. Biotech17 linked2 articles
13d agoYahooTrump Grilled on Midterm Losses, His Own Mortality in ‘60 Minutes’ InterviewTrump, in a 60 Minutes interview with Ross Douthat, acknowledged immigration and messaging missteps after Republican midterm losses, defended the Iran war, and said he could not forgive certain enemies. 11 linked2 articles
13d agoThe GuardianAnti-AI populism is the future of American politics | Garrison LovelyGarrison Lovely's Guardian opinion piece contends that voter backlash against AI datacenters and industry influence after the 2026 midterms makes anti-AI populism the defining political force heading into 2028.1 outletAILawmakers push AI safety bills after GAO chatbot attack-planning test25 linked 13d agoThe GuardianTrump admits deportation policy was ‘too tough’ despite promotion of Stephen MillerTrump concedes in a 60 Minutes interview that his deportation policy was "too tough," proposes a deal with Democrats to let long-term undocumented residents stay, and defends his Iran war and crypto-linked wealth.1 outlet17 linked 13d agoThe GuardianWe can’t just ‘move on’: Democrats must hold Trump accountable | Jan-Werner MüllerA Guardian opinion column urges Democrats, fresh from midterm wins, to hold the Trump administration accountable through testimony, impeachment and legal action rather than moving on. Democrats plan House oversight probes as Blanche won't rule out charges against Garcia13 linked2 articles
- 13d agoThe GuardianEarliestWe can’t just ‘move on’: Democrats must hold Trump accountable | Jan-Werner Müller
- 13d agoThe GuardianPickupTime to fight back: five leading thinkers on what Democrats should do post-midterms
13d agoThe Guardian‘A complete repudiation’: public health won big in US midterm electionsPublic health candidates and issues won broad support in the 2026 US midterm elections, with voters rejecting abortion restrictions and anti-trans measures mixed in results, according to a Guardian report.1 outlet7 linked 13d agoYahooUS FDA orders new eye risk warnings for Ozempic, ZepboundThe FDA ordered GLP-1 weight-loss and diabetes drugs such as Zepbound, Mounjaro, Ozempic and Wegovy to add a potential eye-risk warning (NAION) to their labeling.1 outletBiotech14 linked 13d agoSemaforNew White House chief of staff Miller shuts door on big businessSemafor reports that Stephen Miller replacing Susie Wiles as White House chief of staff closes the channel through which CEOs had softened Trump administration policies, leaving business unsure whom to lobby.1 outlet7 linked 13d agoYahoo · research by Food and Drug AdministrationFDA warns against online weight-loss drugs containing uncertain ingredientsFDA issued a warning letter to Cheap Medicine Shop and a safety alert on dosing errors, cautioning consumers about unapproved online semaglutide weight-loss injections.1 outletBiotech14 linked 13d agoAxiosTrump's AG won't rule out prosecuting Democrats who threaten to investigateBlanche refused on CNN and Fox to rule out criminal charges against Democratic lawmakers, including Rep. Robert Garcia, after Trump ordered DOJ to probe Democrats threatening investigations.1 outletDemocrats plan House oversight probes as Blanche won't rule out charges against Garcia11 linked 13d agoAxiosBlanche dismisses Means allegations as GOP's MAHA feud deepensBlanche brushed off Calley Means' corruption claims against Susie Wiles and her White House allies, as ex-FDA chief Marty Makary and Rep. Marlin Stutzman called for scrutiny of tobacco and kratom lobbying influence.1 outlet15 linked Nov 8PoliticoRep. Robert Garcia: ‘The days of us not fighting back are over’Ranking Democrat Rep. Robert Garcia pledged on CNN to launch Oversight Committee probes of Trump administration officials and family members, while Attorney General Todd Blanche condemned the plan as threats.1 outletDemocrats plan House oversight probes as Blanche won't rule out charges against Garcia12 linked 13d agoPoliticoSanders warns Democrats about spending too much time investigating TrumpSanders urges incoming Democrats to prioritize affordability over investigating Trump and says he will summon RFK Jr. before the HELP committee.1 outlet19 linked Nov 6AxiosEx-RFK Jr. adviser says Trump admin corruption prompted resignationFormer HHS adviser Calley Means says on Joe Rogan that corruption in the Trump administration, including alleged favoritism toward Bayer and lobbyist-linked funding priority, drove his resignation.1 outlet4 linked Nov 2SemaforDemocrats weigh ‘lawfare’ against TrumpSemafor reports that corporate America is readying executives for likely post-midterm Democratic congressional scrutiny over business dealings that courted President Trump. Democrats plan House oversight probes as Blanche won't rule out charges against Garcia51 linked7 articles
- Nov 2SemaforDemocrats weigh ‘lawfare’ against Trump
- Nov 2SemaforPickupDemocrats eye post-election powers
- Nov 3SemaforEarliestCorporate America prepares for post-midterm Democratic backlash
- Nov 4SemaforDemocrats turn scrutiny to tech CEOs and Trump officials
- Nov 4SemaforPickupDemocrats to focus on affordability and corruption probes
- Nov 4Semafor‘Out for blood’: Investigations overshadow dealmaking in newly divided Washington
- Nov 6SemaforDemocrats’ CEO targets remain a work in progress
Nov 4AxiosDemocrats will face a health care stress testAxios analysis says Democrats' post-election health care agenda, including Medicare for All votes and Medicaid cut rollbacks, will be constrained by limits and internal divisions.1 outlet9 linked
On the Hill
Congress, the White House and agencies10Ahead
Tuesday, Nov 24
Tuesday, Jan 5
11:59 PMAgencyFDAFDA is soliciting public feedback through docket FDA-2026-N-13135 on a discussion paper addressing how to weigh benefits and risks of autonomous and remotely teleoperated robotic medical devices, with comments due January 6, 2027.Comment deadlineRoboticsBiotechDetails13 linked 11:59 PMAgencyFDAFDA is taking public comments through January 2027 on a docket tied to a workshop about weighing benefits and risks of robotic medical devices that operate autonomously or via remote teleoperation.Comment deadlineRoboticsDetails13 linked
Friday, Nov 27
Recent
Wednesday, Nov 18
3d agoAgencyFDAFDA's draft guidance on potency assessment for active immunotherapy products is open for public comment under docket FDA-2026-D-8561 until November 19, 2026.Comment deadlineBiotechDetails8 linked 4d agoCongressSenate Health, Education, Labor, and PensionsThe Senate HELP Committee has scheduled a business meeting to consider five executive nominees, including Heidi Overton for FDA Commissioner and James O'Neill for NSF Director.BiotechDetails12 linked 3d agoCongressCommittee on Health, Education, Labor, and PensionsSenate bill S. 5812 would permanently extend HHS authority to award priority review vouchers for rare pediatric disease products, and was referred to the HELP Committee on 2026-11-19.S. 5812BiotechDetails5 linked
Friday, Aug 21
Aug 21CongressHouse Select Committee on the CCPTwo House Republicans on the China committee and an appropriations panel asked the FDA to bar Chinese trial data lacking a recent site audit, citing undisclosed deaths in Chinese gene-editing trials.BiotechDetails34 linked
Friday, Oct 25
Wednesday, Mar 18
Mar 18CongressSenate Committee on Health, Education, Labor, and PensionsThe Senate HELP Committee held a hearing on S. 1387, the National Biotechnology Initiative Act of 2025, on March 19, 2026.S. 1387BiotechDetails3 linked
Nothing from this branch in view.
Times ET
Contracts
Solicitations, SBIR topics, grants and awards0Nothing in contracts is connected to this.